Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:Healthcare
Clear all filters
Rs 15,000 SIP VS Rs 2 Lakh Lump Sum: Here's How Long It May Take To Get You To Rs 2 Crore
neutral
NDTV Profit 1d ago

Rs 15,000 SIP VS Rs 2 Lakh Lump Sum: Here's How Long It May Take To Get You To Rs 2 Crore

Both strategies can eventually create a Rs 2 crore corpus, but they follow very different paths.

TAKEHealthcare
Stock Picks Today: Dr Lal Path, Axis Bank, Syrma SGS, Delhivery, And More On Brokerages' Radar
neutral
NDTV Profit 1d ago

Stock Picks Today: Dr Lal Path, Axis Bank, Syrma SGS, Delhivery, And More On Brokerages' Radar

Brokerages' Radar

AXISBANKBANKINDIABNKETFAXISDELHIVERYLALLALPATHLABSYRMACapital GoodsFinancial Services
Dr Reddy’s pauses weight loss drug on quality fears
positive
ET Markets - Industry 1d ago

Dr Reddy’s pauses weight loss drug on quality fears

Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient manufacturing scale-up. The company assures that already supplied market products remain safe for patient use. Torrent Pharmaceuticals and USV Ltd are recalling some semaglutide batches sourced from Dr Reddy's. Commercial supplies are expected to resume after the issue is resolved and validation is complete.

AONETMMQ50DRREDDYTORNTPHARMFinancial ServicesHealthcare
Cobra India acquires 2.05% stake in Sakar Healthcare via open market - scanx.trade
neutral
Google News - India Markets 1d ago

Cobra India acquires 2.05% stake in Sakar Healthcare via open market - scanx.trade

Cobra India acquires 2.05% stake in Sakar Healthcare via open marketscanx.trade

HCGHCG-REHEALTHCARESAKARFinancial ServicesHealthcare
Biocon shares in focus as Viatris-owned Mylan plans stake sale via block deal: Sources
negative
CNBC TV18 - Markets 1d ago

Biocon shares in focus as Viatris-owned Mylan plans stake sale via block deal: Sources

Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days, according to sources. The size, pricing and buyers are yet to be determined.

BIOCONFOCUSConsumer DurablesHealthcare
Who Is Arnav Paparkar? Indian Teen Tennis Star Who Made History At Wimbledon
negative
NDTV Profit 1d ago

Who Is Arnav Paparkar? Indian Teen Tennis Star Who Made History At Wimbledon

Arnav Paparkar lost 2-6, 5-7 to American Jordan Lee in the Wimbledon boys' singles quarter-finals on July 9, 2026.

STARHealthcare
Trade Setup For July 10: How Nifty May React To TCS Q1 Results — Key Levels To Watch
positive
NDTV Profit 1d ago

Trade Setup For July 10: How Nifty May React To TCS Q1 Results — Key Levels To Watch

Apart from technical levels, the market will also take cues from the start of the earnings season.

AONETMMQ50AONETOTALMOCAPITALTAKETCSFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 1d ago

IKS Health completes acquisition of TruBridge, Inc.

IKS Health announced the successful completion of its previously announced acquisition of TruBridge, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.

HCGHCG-REHEALTHCAREIKSMEDANTAFinancial ServicesHealthcare
Torrent recalls select Semalix diabetes injection pens after Dr Reddy's flags quality issue
neutral
CNBC TV18 - Markets 1d ago

Torrent recalls select Semalix diabetes injection pens after Dr Reddy's flags quality issue

The recall affects only select 2 mg and 4 mg Semalix injection pens manufactured by Dr Reddy's Laboratories, while all other semaglutide products remain unaffected.

ALLETECDRREDDYHealthcareInformation Technology
Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice
positive
ET Markets - Industry 1d ago

Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice

Torrent Pharmaceuticals is voluntarily recalling select batches of its Semalix semaglutide injection pens. This action follows a product recall notification from its manufacturer, Dr. Reddy's Laboratories. Patient safety remains of paramount importance to the company during this process. There is no risk to patients currently using this specific treatment. All other Semaglutide products sold by Torrent remain unaffected.

ALLETECDRREDDYPARAMOUNTTORNTPHARMHealthcareInformation Technology
Sun Pharma among 4 stocks to hit 52-week highs & rally up to 25% in a month
positive
ET Markets - Stocks 1d ago

Sun Pharma among 4 stocks to hit 52-week highs & rally up to 25% in a month

The Sensex ended higher as select BSE 200 stocks touched fresh 52-week highs. FSN E-Commerce Ventures, Titan, Sun Pharmaceutical Industries and Lenskart Solutions led the momentum.

ABSL10BANKBSEBSLSENETFGEQUAL200ESENSEXHDFCSENSEXLENSKARTMIDSELIETFMOIPOMOM30IETFMOMENTUMMOMENTUM30MOMOMENTUMNEXT30ADDNIFTYQLITYNYKAASELECTIPOSENSEXADDSENSEXAXISSENSEXBETASENSEXETFSENSEXIETFSNXT30BEESSNXT50BETASPARCSUNPHARMATITANConsumer DurablesConsumer Services
Govt, Nasscom working on AI curriculum for undergraduate programmes
positive
ET Markets - Industry 1d ago

Govt, Nasscom working on AI curriculum for undergraduate programmes

The government is working with Nasscom to develop an artificial intelligence curriculum for undergraduate programs. This initiative aims to update educational content for the growing use of AI in various sectors. The curriculum review and changes are expected to take approximately six months for finalisation.

TAKEHealthcare